Pages that link to "Q54504564"
Jump to navigation
Jump to search
The following pages link to Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. (Q54504564):
Displaying 50 items.
- Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs (Q26766294) (← links)
- Pathobiology of pulmonary arterial hypertension and right ventricular failure (Q26821779) (← links)
- Immune and inflammatory mechanisms in pulmonary arterial hypertension (Q26851508) (← links)
- The molecular genetics and cellular mechanisms underlying pulmonary arterial hypertension (Q26992278) (← links)
- DNA Damage and Pulmonary Hypertension (Q27005594) (← links)
- Schistosomiasis-associated pulmonary hypertension (Q27006491) (← links)
- Inflammatory cytokines in pulmonary hypertension (Q27007510) (← links)
- Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series) (Q28078976) (← links)
- Lack of bcr and abr promotes hypoxia-induced pulmonary hypertension in mice (Q28512646) (← links)
- Hypertension associated with reduced plasma thrombomodulin levels and a hypercoagulable state in rats (Q28565010) (← links)
- World Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology. (Q30248878) (← links)
- Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection. (Q30397068) (← links)
- A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects (Q30544892) (← links)
- Angiogenic and inflammatory markers of cardiopulmonary changes in children and adolescents with sickle cell disease (Q30945205) (← links)
- IL-32 promotes angiogenesis (Q33555523) (← links)
- Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent (Q33573360) (← links)
- T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension (Q33679052) (← links)
- Effects of exercise training on pulmonary hemodynamics, functional capacity and inflammation in pulmonary hypertension (Q33738592) (← links)
- Kidney dysfunction in patients with pulmonary arterial hypertension (Q33738621) (← links)
- N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats (Q33786092) (← links)
- The cancer theory of pulmonary arterial hypertension (Q33788493) (← links)
- Lack of elevation in plasma levels of pro-inflammatory cytokines in common rodent models of pulmonary arterial hypertension: questions of construct validity for human patients (Q33788533) (← links)
- Erythropoietin upregulation in pulmonary arterial hypertension (Q33805982) (← links)
- Tissue wasting in patients with chronic obstructive pulmonary disease (Q33829486) (← links)
- Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension (Q33898213) (← links)
- Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension (Q33909537) (← links)
- Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)-Induced Pulmonary Hypertension (Q33920050) (← links)
- Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseases (Q33965825) (← links)
- Novel mechanisms of sildenafil in pulmonary hypertension involving cytokines/chemokines, MAP kinases and Akt. (Q34061821) (← links)
- Increased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infection (Q34109306) (← links)
- Primary pulmonary hypertension in HIV patients: a systematic review. (Q34155622) (← links)
- Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1 (Q34178976) (← links)
- Fetal production of growth factors and inflammatory mediators predicts pulmonary hypertension in congenital diaphragmatic hernia (Q34182389) (← links)
- Chronic allergic inflammation causes vascular remodeling and pulmonary hypertension in BMPR2 hypomorph and wild-type mice (Q34199837) (← links)
- Neuroinflammation in pulmonary hypertension: concept, facts, and relevance (Q34205701) (← links)
- Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertension (Q34250971) (← links)
- Nuclear factor κB inhibition reduces lung vascular lumen obliteration in severe pulmonary hypertension in rats. (Q34305561) (← links)
- Human alveolar macrophages and monocytes as a source and target for nitric oxide (Q34342634) (← links)
- Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats (Q34357126) (← links)
- Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension (Q34466439) (← links)
- Estrogens and Development of Pulmonary Hypertension: Interaction of Estradiol Metabolism and Pulmonary Vascular Disease (Q34524900) (← links)
- Matrix metalloproteinase-9 and plasminogen activator inhibitor-1 are associated with right ventricular structure and function: the MESA-RV Study (Q34609134) (← links)
- Functions of serotonin in hypoxic pulmonary vascular remodeling (Q34653768) (← links)
- Role for miR-204 in human pulmonary arterial hypertension (Q34681312) (← links)
- Schistosomiasis and the pulmonary vasculature (2013 Grover Conference series) (Q34782431) (← links)
- Interleukin 13- and interleukin 17A-induced pulmonary hypertension phenotype due to inhalation of antigen and fine particles from air pollution (Q34782588) (← links)
- Pulmonary hypertension in autoimmune rheumatic diseases: where are we now? (Q34810661) (← links)
- The crossroads of iron with hypoxia and cellular metabolism. Implications in the pathobiology of pulmonary hypertension (Q34924892) (← links)
- Evaluation of circulating proteins and hemodynamics towards predicting mortality in children with pulmonary arterial hypertension (Q35053507) (← links)
- Unrecognized glucose intolerance is common in pulmonary arterial hypertension (Q35085796) (← links)